Vifor Pharma, a part of Switzerland-based Galenica Group (SIX: GALN) develops pharmaceutical products for the treatment of iron deficiency. Vifor Pharma, a part of Switzerland-based Galenica Group ...

Vifor Pharma has forged a strategic partnership with Fresenius Kabi, focusing on marketing a portfolio of iron deficiency drugs. The partnership expands Vifor Pharma’s cooperation with Fresenius ...

Travere Therapeutics and partner CSL Vifor could be weeks away from EU approval ... advocacy organisations as they increasingly rely on pharma funding. Join the conversation, on Tuesday 28th ...

NervGen Pharma (TSE:NGEN) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly ...

In the new year, the Indian pharmaceutical sector will have to grapple with new realities, at home and overseas. On home ground, the updated Uniform Code for Pharmaceutical Marketing Practices ...

A former Takeda Pharmaceutical worker was forced to forfeit her Mercedes-Benz, Seaport condominium and diamond ring after being sentenced to prison for embezzling over $2.5 million from the ...

Test tubes is seen labelled "Bird Flu" words in front of U.S. flag in this illustration taken, June 10, 2024. REUTERS/Dado Ruvic/Illustration A U.S. patient who had been hospitalized with H5N1 ...

Moreover, the centre’s production-linked incentive (PLI) scheme for the pharma industry has benefited the sector significantly. Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance ...

Shares of Neumora Therapeutics fell more than 80% after its depression drug failed in a key trial. The drug failed to reduce symptoms like sadness and pessimistic thoughts in people diagnosed with ...

Austrian arenaviral technology firm HOOKIPA Pharma (Nasdaq: HOOK) and Poolbeg Pharma (AIM: POLB) have entered into non-binding discussions for an all-share acquisition by HOOKIPA of London-listed ...

On Wednesday, H.C. Wainwright initiated coverage on NASDAQ-listed TuHURA Biosciences (NASDAQ: HURA), assigning a Buy rating and a price target of $11.00. Currently ...

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...